Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

hTEPs (human tissue engineered products) change of sovereignty at the EC: a taste of things to come?

This article was originally published in Clinica

Executive Summary

The transfer of the file on human tissue engineered products into the pharmaceutical unit of the European Commission, just as a first draft Regulation was about to appear, is not only frustrating for industry but also raises serious questions about the manner in which the decision was made, writes Amanda Maxwell.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055120

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel